Revenue grew 10% year-over-year to $11.99B in Q2 2026, with 5% organic growth and strong performance across all segments. Adjusted EPS rose 13% to $6.03, and the company repurchased $1.0B in stock while launching new products and expanding strategic collaborations.Original document: Thermo Fisher S…
Revenue grew 10% year-over-year to $11.99B in Q2 2026, with 5% organic growth and strong performance across all segments. Adjusted EPS rose 13% to $6.03, and the company repurchased $1.0B in stock while launching new products and expanding strategic collaborations.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.